Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

LKN — Predicate Candidate Screening

27 FDA 510(k) clearances under this product code; the 50 most recent screened below.

113 daysmedian FDA review time
302 days90th percentile
27clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K192150AMICUS Separator SystemFresenius Kabi AG2019-11-13960
K183081Spectra Optia Apheresis SystemTerumobct, Inc.2019-02-05910
K180615AMICUS Separator System, AMICUS Exchange Kit - Therapeutics,Fresenius Kabi USA,Llc2018-12-042712
K181049Spectra Optia Apheresis SystemTerumobct, Inc.2018-11-011950
K172590Spectra Optia Apheresis SystemTerumobct, Inc.2018-03-021850
K153601Spectra Optia Apheresis SystemTerumobct, Inc.2016-01-14290
K151368Spectra Optia Apheresis System, Spectra Optia Exchange Set (Terumo Bct2015-09-111130
K141938SPECTRA OPTIA APHERESIS SYSTEM, SPECTRA OPTIA EXCHANGE SET (Terumobct, Inc.2015-03-232490
K141019AMICUS SEPARATOR SYSTEM/ AMICUS SEPERATOR SYSTEM;REFURBISHEDFenwal, Inc.2014-06-10500
K132429SPECTRA OPTIA APHERESIS SYSTEM, SPECTRA OPTIA SYSTEM SOFTWARTerumobct, Inc.2013-12-061230
K131744SPECTRA OPTIA APHERESIS SYSTEM, SPECTRA OPTIA SINGLE-NEEDLE Terumobct, Inc.2013-08-08560
K111702AMICUS SEPARATOR SYSTEM- USE IN THERAPEUTIC PLASMA EXCHANGE Fenwal, Inc.2012-03-222791
K113480SPECTRA OPTIA APHERESIS SYSTEMCaridianbct, Inc..2012-01-20580
K103090SPECTRA OPTIA R APHERESIS SYSTEMCaridianbct, Inc..2010-11-19314
K071079SPECTRA OPTIA APHERESIS SYSTEM, SPECTRA OPTIA EXCHANGE SET, Gambro Bct, Inc.2007-08-021074
K060734FRESENIUS COM.TEC AUTOMATED CELL SEPARATOR, MODEL 9008031; FFresenius Medical Care North America2006-09-051690
K050273FRESENIUS ART HEMOADSORPTION SYSTEMFresenius Medical Care North America2005-06-081210
K961706P1R PLASMA TREATMENT SET FOR USE IN PLASMAPHERESIS WITH THE Fresenius USA, Inc.1996-07-31901
K953681HAEMONETICS THERAPEUTIC PLASMA EXCHANGE SETHaemonetics Corp.1996-06-043020
K926409PLASMA DISCARD BAGSApheresis Technologies, Inc.1993-03-02710
K900105COBE SPECTRA BLOOD COMPONENT SEPARATOR THERAPEUTICCobe Laboratories, Inc.1991-03-224370
K895435FRESENIUS AS 104 CELL SEPARATORFresenius USA, Inc.1990-11-024210
K893962COBE 2991 SUPPLEMENTARY DISPOSABLE SETSCobe Laboratories, Inc.1989-10-181380
K874607FOUR LITER BAG FOR USE W/REDY 2000/DIALERT SYSTEMSOrganon Teknika Corp.1988-01-27790
K850621GAMBRO PLASMAFILTRATION SYSTEMGambro, Inc.1985-05-16900
K831004AUTOMATED 8400 BLOOD CELL SEPARATORIntl. Business Machines1983-09-121670
K830831AUTOMATED BLOOD CELL SEPARATORCryosan, Inc.1983-06-16920

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda